HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhen Guo Selected Research

Nasopharyngeal Carcinoma

1/2021LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma.
1/2021Genetic Polymorphisms of Long Non-coding RNA Linc00312 Are Associated With Susceptibility and Predict Poor Survival of Nasopharyngeal Carcinoma.
1/2019A Functional 5'-UTR Polymorphism of MYC Contributes to Nasopharyngeal Carcinoma Susceptibility and Chemoradiotherapy Induced Toxicities.
11/2017Author Correction: Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.
9/2017Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients.
1/2017BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma.
1/2017Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhen Guo Research Topics

Disease

63Neoplasms (Cancer)
03/2022 - 01/2003
25Crohn Disease (Crohn's Disease)
12/2021 - 04/2013
18Inflammation (Inflammations)
08/2022 - 04/2012
11Colitis
08/2022 - 02/2015
9Hypoxia (Hypoxemia)
08/2022 - 08/2015
8Infections
07/2022 - 02/2010
8Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2018
8Pain (Aches)
01/2020 - 06/2017
7Nasopharyngeal Carcinoma
01/2021 - 01/2017
6Cardiotoxicity
01/2022 - 01/2019
6Neoplasm Metastasis (Metastasis)
01/2021 - 01/2003
5Hypertrophy
01/2022 - 01/2018
5Ischemia
06/2016 - 09/2013
4Fibrosis (Cirrhosis)
08/2022 - 01/2019
4Hemorrhage
02/2022 - 03/2009
4Reperfusion Injury
01/2022 - 02/2010
4Carcinogenesis
01/2022 - 01/2014
4Hepatocellular Carcinoma (Hepatoma)
05/2017 - 03/2011
3Alzheimer Disease (Alzheimer's Disease)
07/2022 - 01/2020
3Thrombosis (Thrombus)
02/2022 - 01/2020
3Myocardial Infarction
01/2022 - 05/2016
3Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2014
3Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 05/2013
3Breast Neoplasms (Breast Cancer)
03/2021 - 12/2019
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2020
3Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 01/2019
3Hypersensitivity (Allergy)
01/2020 - 01/2018
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 01/2016
3Intestinal Obstruction (Obstruction, Intestinal)
08/2019 - 04/2013
3Ulcerative Colitis
01/2019 - 09/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2015 - 10/2014
2Melanoma (Melanoma, Malignant)
03/2022 - 12/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2021
2Anemia
12/2021 - 01/2019
2COVID-19
02/2021 - 01/2020
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
01/2021 - 01/2020
2Hyperalgesia
01/2020 - 01/2018
2Cardiomyopathies (Cardiomyopathy)
01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2009
14Pharmaceutical PreparationsIBA
01/2022 - 08/2014
12Biomarkers (Surrogate Marker)IBA
07/2022 - 10/2012
10MicroRNAs (MicroRNA)IBA
07/2020 - 01/2015
8Long Noncoding RNAIBA
05/2022 - 12/2014
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2019
5EnzymesIBA
01/2022 - 02/2010
5Messenger RNA (mRNA)IBA
01/2022 - 01/2018
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2016
5Therapeutic UsesIBA
10/2021 - 01/2016
5Glutathione (Reduced Glutathione)IBA
07/2021 - 10/2020
4Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2022 - 12/2018
4Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022 - 12/2013
4Peptides (Polypeptides)IBA
12/2021 - 02/2011
4artemisinin (artemisinine)IBA
07/2021 - 08/2014
4CateninsIBA
10/2020 - 05/2017
4C-Reactive ProteinIBA
01/2020 - 07/2015
4Small Interfering RNA (siRNA)IBA
01/2019 - 12/2009
4Interleukin-10 (Interleukin 10)IBA
10/2018 - 12/2013
3HydrogelsIBA
07/2022 - 01/2020
3Biological ProductsIBA
05/2022 - 10/2014
3Circular RNAIBA
01/2022 - 01/2021
3ImmunosorbentsIBA
01/2022 - 02/2010
3Sirtuin 1IBA
01/2022 - 08/2015
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2016
3AntioxidantsIBA
01/2022 - 07/2012
3Azathioprine (Imuran)FDA LinkGeneric
12/2021 - 01/2013
3Interleukin-6 (Interleukin 6)IBA
03/2021 - 01/2018
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2011
3CytokinesIBA
01/2021 - 01/2017
31-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 11/2018
3Freund's AdjuvantIBA
01/2020 - 01/2019
3AlbuminsIBA
01/2020 - 02/2010
3IronIBA
01/2019 - 08/2014
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 01/2016
3Toll-Like Receptor 4IBA
12/2018 - 06/2016
3IonsIBA
08/2018 - 08/2014
2Heparin (Liquaemin)FDA LinkGeneric
02/2022 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2021
2Sirtuin 3IBA
01/2022 - 01/2019
2Adenosine Triphosphate (ATP)IBA
01/2022 - 01/2019
2Phosphates (Orthophosphate)IBA
12/2021 - 09/2016
2ZincIBA
10/2021 - 07/2018
2Metformin (Glucophage)FDA LinkGeneric
09/2021 - 01/2020
2TransferasesIBA
03/2021 - 12/2020
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2020
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2021 - 10/2012
2LipidsIBA
11/2020 - 01/2020
2Metal-Organic FrameworksIBA
10/2020 - 01/2017
2Photosensitizing Agents (Photosensitizers)IBA
10/2020 - 02/2020

Therapy/Procedure

31Therapeutics
02/2022 - 03/2009
9Drug Therapy (Chemotherapy)
12/2020 - 08/2015
7Radiotherapy
01/2021 - 07/2013
7Enteral Nutrition (Feeding, Tube)
01/2019 - 04/2013
4Precision Medicine
07/2019 - 01/2016
4Chemoradiotherapy
01/2019 - 01/2017
3Extracorporeal Membrane Oxygenation
02/2021 - 03/2009
3Photochemotherapy (Photodynamic Therapy)
10/2020 - 01/2020
3Photothermal Therapy
11/2018 - 01/2016
3Operative Surgical Procedures
04/2018 - 02/2010
2Oxygenators
02/2021 - 05/2016